Verastem (VSTM) EBT (2011 - 2026)

Verastem's EBT history runs 16 years deep, the most recent figure standing at -$44.5 million for Q1 2026.

• In Q1 2026, EBT changed 0.11% year-over-year to -$44.5 million; the TTM figure through Mar 2026 stood at -$183.5 million (down 39.04% YoY), while the FY2025 annual figure was -$209.5 million, down 60.57% from the prior year.
• EBT for Q1 2026 stood at -$44.5 million, down from -$40.8 million in the prior quarter.
• The five-year high for EBT was -$16.8 million in Q4 2022, with the low at -$54.0 million in Q2 2025.
• The 5-year median for EBT is -$30.4 million (2023), against an average of -$30.0 million.
• The sharpest annual moves came in 2022 and 2025: EBT jumped 36.87% in 2022, then tumbled 192.7% in 2025.
• Verastem's EBT stood at -$16.8 million in 2022, then slumped by 80.88% to -$30.4 million in 2023, then slipped by 4.53% to -$31.8 million in 2024, then slipped by 28.39% to -$40.8 million in 2025, then decreased by 9.0% to -$44.5 million in 2026.
• Business Quant data shows VSTM's EBT at -$44.5 million in Q1 2026, -$40.8 million in Q4 2025, and -$44.3 million in Q3 2025.